Drug Type Small molecule drug |
Synonyms TQ B3456, TQ-B3456, TQB-3456 |
Target |
Action antagonists |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
metastatic non-small cell lung cancer | Phase 1 | China | 24 Sep 2020 | |
Non-Small Cell Lung Cancer | IND Application | China | 18 Aug 2017 |